Kryptochem Medicament Private Limited
About Kryptochem Medicament Private Limited
Data last updated:
Kryptochem Medicament Private Limited is a private limited company based in Ambala Cantt, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 29 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24232HR2019PTC078174. Its GSTIN is 06AAHCK4726D1ZQ (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Naresh Kumar and Varun Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Mohra Dukeri Road Markanda Complex Near Cipla Depot, Ambala Cantt, Haryana, India – 133004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.14 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹32,193 (net margin 0.3%) and EBITDA of ₹60,402 (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 21% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressVillage Mohra Dukeri Road Markanda Complex Near Cipla Depot, Ambala Cantt, Haryana, India – 133004
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Kryptochem Medicament Private Limited
The main business activity of Kryptochem Medicament is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Kryptochem Medicament Private Limited FY 2025 filings available
Kryptochem Medicament Private Limited reported revenue of ₹1.14 Cr (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Kryptochem Medicament Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 17% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Kryptochem Medicament Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹60,402 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹32,193 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Kryptochem Medicament Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Kryptochem Medicament are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Kryptochem Medicament Private Limited
Kryptochem Medicament Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Silisis Ceramica Private Limited | •••• | •••• | •••• | •••• | - | Hyderabad, Telangana, India |
| Abachem Specialty Chemicals Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Aishin India Private Limited | •••• | •••• | •••• | •••• | - | Thane (West), Maharashtra, India |
| Wrushi Medihall 24 Private Limited | •••• | •••• | •••• | •••• | - | Ahmednagar, Maharashtra, India |
| Bahubali Exim Private Limited | •••• | •••• | •••• | •••• | - | Surat, Gujarat, India |
| Kryptochem Medicament Private Limited this company | •••• | •••• | •••• | •••• | - | Ambala Cantt, Haryana, India |
| Uko Pharmatech Private Limited | •••• | •••• | •••• | •••• | - | Chandigarh, India |
| Micro Chem Products(India)Private Limited | •••• | •••• | •••• | •••• | - | Chennai 16, Tamil Nadu, India |
| Flavourite Foods Private Limited | •••• | •••• | •••• | •••• | - | Kolkata, West Bengal, India |
| Kampibell Bathware Private Limited | •••• | •••• | •••• | •••• | - | Jalandhar, Punjab, India |
| Pepcon Confectioners Private Limited | •••• | •••• | •••• | •••• | - | Noida, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Kryptochem Medicament by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Board of Directors of Kryptochem Medicament Private Limited
Kryptochem Medicament has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Kumar | Director | 29 Jan 2019 | 7 Years 8 Months | Current |
| Varun Singla Also directs: Yavinox Lifecare Private Limited | Director | 29 Jan 2019 | 7 Years 8 Months | Current |
Ownership and Shareholding of Kryptochem Medicament Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Kryptochem Medicament Private Limited
Kryptochem Medicament Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Kryptochem Medicament Private Limited
Employment history and EPFO contributions of people linked to Kryptochem Medicament.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Kryptochem Medicament Private Limited
Kryptochem Medicament Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Naresh Kumar was appointed as Director on 29 Jan 2019.
Credit Ratings, Litigation & Regulatory Alerts for Kryptochem Medicament Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Kryptochem Medicament Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Kryptochem Medicament Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Kryptochem Medicament Private Limited
Kryptochem Medicament has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCK4726D1ZQ | Haryana | Active | 15 Feb 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Kryptochem Medicament Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kryptochem Medicament Private Limited
Kryptochem Medicament is an active private limited company based in Ambala Cantt, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 29 January 2019 (7+ years old) and is registered under CIN U24232HR2019PTC078174.
Kryptochem Medicament reported revenue of ₹1.14 Cr for FY 2025 (up 17% YoY).
Kryptochem Medicament has 2 current directors:
- Naresh Kumar - Director
- Varun Singla - Director
Kryptochem Medicament reported a net profit of ₹32,193 (net margin 0.3%) and EBITDA of ₹60,402 (EBITDA margin 0.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Kryptochem Medicament is 8% over three years and 21% over five years. In the latest year (FY 2025) revenue rose 17%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Kryptochem Medicament is 06AAHCK4726D1ZQ, registered in Haryana.
The CIN (Corporate Identification Number) of Kryptochem Medicament is U24232HR2019PTC078174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kryptochem Medicament was incorporated on 29 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Kryptochem Medicament by revenue are Silisis Ceramica Private Limited, Abachem Specialty Chemicals Private Limited, Aishin India Private Limited, Wrushi Medihall 24 Private Limited, Bahubali Exim Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Naresh Kumar was appointed as Director on 29 Jan 2019. Varun Singla was appointed as Director on 29 Jan 2019.
The registered office of Kryptochem Medicament is at Village Mohra Dukeri Road Markanda Complex Near Cipla Depot, Ambala Cantt, Haryana, India – 133004.